Invitation to Presentations of Senzime's Q4 and Year-End Report 2025

Rhea-AI Summary

Senzime (OTCQX:SNZZF) invites investors, analysts and media to a webcast presenting its fourth quarter and year-end report for 2025 on February 18, 2026 at 09:00 CET. The written report will be published the same morning.

Philip Siberg, CEO, will present via webcast on Senzime's investor site and will join a Q&A interview hosted by Gustaf Meyer of Redeye in the afternoon. Questions for the Q&A can be emailed in advance to gustaf.meyer@redeye.se no later than February 18, 10:00 am CET. Contact details for CEO Philip Siberg are provided for further information.

UPPSALA, SE / ACCESS Newswire / February 11, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter and year-end report for 2025 on February 18, 09:00 CET. The report will be published during the morning of the same day.

Philip Siberg, CEO of Senzime, will present the report through a webcast available at Senzime's website https://www.senzime.com/investors

In the afternoon of February 18, Gustaf Meyer, analyst at Redeye, will host a Q&A interview with Philip Siberg. The recording of the Q&A will be published later the same day at Redeye's website https://www.redeye.se/company/senzime

Questions for the Q&A interview can be emailed in advance, no later than February 18, 10:00 am CET, to gustaf.meyer@redeye.se

For further information, please contact:

Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com

About Senzime

Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies. Established in 1999, Senzime develops and markets precision-based monitoring systems that improve outcomes, reduce costs, and advance perioperative patient safety. The flagship solution is the TetraGraph® system, proven best-in-class for accurate monitoring of neuromuscular transmission during surgery and used in thousands of operating rooms across the globe. The system helps to secure precise dosing of paralytic drugs and provides enhanced insights to safeguard every patient's journey, from anesthesia to recovery.

Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the US OTCQX Market (SNZZF), and backed by long-term investors. More information is available at senzime.com.

Attachments

Invitation to presentations of Senzime's Q4 and Year-End Report 2025

SOURCE: Senzime

View the original press release on ACCESS Newswire

FAQ

When is Senzime's (SNZZF) Q4 and year-end 2025 webcast presentation scheduled?

The webcast presenting Senzime's Q4 and year-end 2025 report is scheduled for February 18, 2026 at 09:00 CET. According to Senzime, the written report will be published during the morning of the same day and the webcast is on the investor website.

Where can investors watch the Senzime (SNZZF) February 18, 2026 webcast?

Investors can watch the webcast on Senzime's investor relations website at the time of the presentation. According to Senzime, the live webcast link will be available on https://www.senzime.com/investors and the presentation will be hosted by the CEO.

How can I submit questions for the Senzime (SNZZF) Q&A with Redeye on February 18, 2026?

Submit questions by email to gustaf.meyer@redeye.se no later than February 18, 2026 at 10:00 am CET. According to Senzime, pre-submitted questions will be considered for the afternoon Q&A interview hosted by Redeye's analyst Gustaf Meyer.

Who will present Senzime's (SNZZF) Q4 and year-end 2025 report during the webcast?

Philip Siberg, CEO of Senzime, will present the Q4 and year-end 2025 report during the webcast. According to Senzime, he will also participate in an afternoon Q&A interview conducted by Gustaf Meyer from Redeye.

When will the Q&A recording with Redeye about Senzime (SNZZF) be available?

The Q&A recording will be published later on February 18, 2026 after the live interview. According to Senzime, Redeye will host the recorded Q&A on its website at https://www.redeye.se/company/senzime for later viewing.

Who can I contact for further information about Senzime (SNZZF) investor events?

For further information contact Philip Siberg, CEO of Senzime, via the phone or email provided in the announcement. According to Senzime, contact details include phone +46 (0) 707 90 67 34 and philip.siberg@senzime.com.